Shawn Guertin Will Join Davida’s BOD Effective September 15

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

September 8, 2020

Shawn Guertin will join the Davida board of directors, effective Sept. 15.

Shaw Guertin joins the Board with nearly 35 years of health care experience.  Most recently, Mr. Guertin spent eight years at Aetna, Inc., where he served as executive vice president, chief financial officer and chief enterprise risk officer during a period of significant growth driven by acquisitions and expansion into government programs, leading to Aetna’s eventual merger into CVS Health. At Aetna, Mr. Guertin was a key member of the executive leadership team driving the overall strategic direction of the enterprise and leading the development of the financial strategy to help grow the company into a multifaceted, dynamic health care organization.

“We are thrilled to have Shawn’s deep health care and managed care experience as part of our Board to help us continue to develop and execute on our strategy to transform kidney care,” said Javier Rodriguez, CEO of DaVita Inc. “He adds to our deep bench of financial and operational strength.”

“The expertise Shawn has cultivated throughout his career and, most recently at Aetna and CVS Health, will help DaVita continue to grow and lead within the larger health care community,” said Pam Arway, independent chair of the DaVita Inc. Board of Directors.

Mr. Guertin started his career as an actuary for The Travelers, where he held a number of roles over 11 years, eventually becoming part of the leadership of its group health business that was acquired by UnitedHealthcare.  After working for UnitedHealthcare, Guertin joined Coventry Health Care, where he spent 12 years, including serving as chief actuary and chief financial officer.

“DaVita’s commitment to its patients, teammates, partners and to true transformation in health care was part of the inspiration to join this team,” said Mr. Guertin. “I am excited to share my perspectives on managed care, capital planning and strategic direction as DaVita executes on its innovative strategy.”

Mr. Guertin will serve on DaVita’s audit committee. He also holds a position on the TriNet Board of Directors.

With the addition of Mr. Guertin, the DaVita Board is comprised of ten highly qualified directors, with 40% racial/ethnic and 40% gender diversity.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.